K. David Campagnari

President at Induce Biologics, Inc.

Health Technology

Consumer Services

Profile

K.
David Campagnari is currently the President & Chief Operating Officer at Induce Biologics, Inc. He previously worked as the Vice President-Operations at MIGENIX, Inc. from 2002 to 2010.
He received his undergraduate degree and MBA from National University.

K. David Campagnari active positions

Companies	Position	Start
Induce Biologics, Inc. Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada.	President	-

All active positions of K. David Campagnari

Former positions of K. David Campagnari

Companies	Position	End
MIGENIX, Inc. MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.	Chief Operating Officer	23/03/2010

See the detail of K. David Campagnari's experience

Training of K. David Campagnari

National University

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of K. David Campagnari's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
MIGENIX, Inc. MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.	Health Technology
Induce Biologics, Inc. Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada.	Health Technology